According to Futurewise analysis, the C-reactive protein (CRP) assays for research use only (RUO) and the IVD market in 2024 were US$990.69 million and are expected to grow at a CAGR of 5% by 2032. The market is growing mainly because more people have cardiovascular diseases and inflammatory conditions around the world. These conditions need accurate biomarker tests for diagnosis and monitoring. The use of point-of-care testing devices and automated laboratory instruments is also helping the market grow. Additionally, more people are becoming aware of preventive healthcare, and CRP testing is being included in regular health screenings, which keeps demand steady for both clinical and research uses.
C-reactive protein (CRP) assays are laboratory tests designed to quantify the levels of C-reactive protein, which is a substance produced by the liver during periods of inflammation. This protein serves as a biomarker indicating the presence of inflammation in the body. CRP levels can rise in response to a variety of health issues, including infections, chronic diseases, and inflammatory conditions.
Innovative Technologies and Formats-
- Portable and Point-of-Care (POC) Devices: Fast, handheld CRP analyzers are becoming widely available, some delivering results in just a few minutes and even connecting to smartphones for easier monitoring.
- Next-Generation ELISAs: High-sensitivity CRP kits now provide faster results, with many pre-coated or ready-to-use formats that reduce lab preparation time.
- Nanotech & Biosensor Breakthroughs: Advanced biosensors, including plasmon-assisted and nanobody-modified platforms, enable highly sensitive and multiplexed CRP detection.
Market Growth- The global market for C-reactive protein (CRP) testing is experiencing significant growth, with projections estimating it will reach a value of $5–6 billion by the year 2030. This expansion is primarily driven by the rising trend of home testing, the ongoing need for chronic disease monitoring, and the increasing adoption of advanced immunoturbidimetric assays in clinical settings.
These assays play a crucial role in both clinical and research settings. Clinically, they are used to help diagnose and monitor conditions such as autoimmune diseases, infections, and other inflammatory disorders. They can also help evaluate the effectiveness of treatments aimed at reducing inflammation. In research, CRP assays contribute to studies exploring the links between inflammation and various diseases, enhancing our understanding of the body's inflammatory processes and potential therapeutic interventions. Overall, monitoring CRP levels is an essential tool for assessing a patient’s health and guiding treatment decisions.
FutureWise Market Research has released a report providing an in-depth analysis of Market trends that will impact overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.